Intensive care unit

Antibiotic Policies: Theory and Practice

Volumn , Issue , 2005, Pages 261-279

  Hanberger, Hakan ^a   Monnet, Dominique L ^b   Nilsson, Lennart E ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 29944435662     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/0-387-22852-7_15     Document Type: Chapter

References (88)

1. Allaouchiche, B., Monnet, D., López-Lozano, J., Müller-Pebody, B., Ayzac, L., Tigaud, S. et al., 2002, Incidence of ICU-acquired infections due to antimicrobial-resistant microorganisms and relationships with antimicrobial use, infection control and workload in a French ICU. 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA, abstr. K-1346.
2. Aksaray, S., Dokuzoguz, Guvener, E. et al., 2000, Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in eight hospitals in Turkey. J. Antimicrob. Chemother, 45, 695-699.
3. Albrich, W. C., Angstwurm, M., Bader, L., and Gartner, R., 1999, Drug resistance in intensive care units. Infection, 27(Suppl. 2), S19-S23.
4. Andersen, C. T., and Meberg, A., 1999, [Drug use in a neonatal unit]. Tidsskr Nor Lægeforen, 119, 197-200.
5. Archibald, L., Phillips, L., Monnet, D., McGowan, J. E., Tenover, F., and Gaynes, R., 1997, Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit. Clin. Infect. Dis., 24, 211-215.
6. Bailey, T. C. and McMullin, S. T., 2001, Using information systems technology to improve antibiotic prescribing. Crit. Care Med., 29(Suppl.), 87-91.
7. Baughman, R P., 2002, Antibiotic resistance in the intensive care unit. Curr Opin. Crit. Care, 8, 430-434.
8. Bergmans, D C., Bonten, M. J., Gaillard C. A., van Tiel, F. H., van der Geest, S., de Leeuw, P. W. et al., 1997, Indications for antibiotic use in ICU patients: A one-year prospective surveillance. J. Antimicrob. Chemother, 39, 527-535.
9. Bergogne-Berezin, E., 1999, Current guidelines for the treatment and prevention of nosocomial infections. Drugs, 58, 51-67.
10. Bonten, M. J., Austin, D. J., and Lipsitch, M., 2001, Understanding the spread of antibiotic resistant pathogens in hospitals: Mathematical models as tools for control. Clin. Infect. Dis., 33, 1739-1746.
11. Bonten, M. J., 2002, Infection in the intensive care unit: Prevention strategies. Curr Opin. Infect. Dis., 15, 401-405.
12. Bonten, M. J., and Mascini, E. M., 2003, The hidden faces of the epidemiology of antibiotic resistance. Intensive Care Med., 29, 1-2.
13. Bonten, M. J., Joore, H. C, de Jongh, B. M. et al., 2003, Selective decontamination of the digestive tract: All questions answered? Crit. Care, 7, 203-205.
14. Borderon, J. C, Laugier, J., Ramponi, N, Saliba, E., Gold, F., and Blond M. H., 1992, Surveillance of antibiotic therapy in a pediatric intensive care unit. Ann. Pediatr. (Paris), 39, 27-36.
15. Bourdain, N, Lepape, A., Galzot, F., Lamy, B., Haessler, D., Chomarat, M. et al., 1999, Peut-on utiliser des protocoles d'antibiothérapie probabiliste en réanimation? Pathol. Biol., 47, 584-588.
16. Boyce, J. M., Potter-Bynoe, G., Chenevert, C., and King, T., 1997, Environmental contamination due to methicillinresistant Staphylococcus aureus: Possible infection control implications. Infect. Control Hosp. Epidemiol., 18, 622-627.
17. Burke, J. P. and Pestotnik, S. L., 1999, Antibiotic use and microbial resistance in intensive care units: Impact of computer-assisted decision support. J. Chemother, 11, 530-535.
18. Burwen, D. R., Banerjee, S. N, Gaynes, R. P., and the National Nosocomial Infections Surveillance System, 1994, Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States. J. Infect. Dis., 170, 1622-1625.
19. Capellà, D., 1993, Descriptive tools and analysis. WHO Reg. Publ. Eur. Ser, 45, 55-78.
20. Carmeli, Y., Eliopoulos, G, Mozaffari, E., and Samore, M., 2002, Health and economic outcomes of vancomycin-resistant enterocci. Arch. Intern. Med., 162, 2223-2228.
21. Cars, O., Mölstad S., and Melander, A., 2001, Variation in antibiotic use in the European Union. Lancet, 357, 1851-1853.
22. Centers for Disease Control and Prevention, 1997, Update: Staphylococcus aureus with reduced susceptibility to vancomycin-United States, 1997. MMWR, 46, 813-815.
23. Centers for Disease Control and Prevention, 2002, Staphylococcus areus resistant to vancomycin-United States, 2002. MMWR, 51, 565-567.
24. DANMAP 2000, Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals and humans in Denmark. Danish Veterinary Laboratory. Copenhagen, Denmark. 2001. Available from http://www.dfvf.dk/Files/Filer/Zoonosecentret/Publikationer/Danmap/Danmap-2000. pdf
25. De Jonge, E., Schultz, M. J., Spanjaard L. et al., 2002, European Society of Intensive Care Medicine, 15th Annual Congress (Barcelona): Effects of selective decontamination of the digestive tract on mortality and antibiotic resistance (abstract 30). Intensive Care Med., 28(Suppl. 1), S12.
26. Diaz, E. and Rello, J., 2002, Top ten list in antibiotic policy in the ICU. Chest, 122, 712-714.
27. Diekema, D. J., Pfaller, M. A., Jones, R. N, Doern, G V, Winokur, P. L., Gales, A. C. et al., and the SENTRY participants group (Americas), 1997, Survey of bloodstream infections due to gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the Sentry antimicrobial surveillance program. Clin. Infect. Dis., 29, 595-607.
28. Diekema, D J., Pfaller, M. A., Schmitz, F J. et al., and the SENTRY Participants Group, 2001, Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific for the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis., 32(Suppl 2), S114-S132.
29. Eggimann, P., Harbarth, S., Constantin, M. N, Touveneau, S., Chevrolet, J. C, and Pittet, D, 2000, Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet, 355, 1864-1868.
30. Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N, and Wenzel, R. P., 1999, Nosocomial bloodstream infections in United States hospitals: A three-year analysis. Clin. Infect. Dis., 29, 239-244.
31. Erlandsson, C.-M., Hanberger, H., Eliasson, I., Hoffmann, M., Isaksson, B., Lindgren, S. et al., 1999, Surveillance of antibiotic resistance in ICUs in south-eastern Sweden. Acta Anaesthesiol. Scand., 43, 815-820.
32. Evans, R S., Pestotnik, S. L., Classen, D. C, et al., 1998, A computer-assisted management program for antibiotics and other anti-infective agents. N. Engl. J. Med. 338, 232-238.
33. Fischer, J. E., Ramser, M., and Fanconi, S., 2000, Use of antibiotics in pediatric intensive care and potential savings. Intensive Care Med., 26, 959-966.
34. Fonseca, S. N, Ehrenkranz, R. A., and Baltimore, R. S., 1994, Epidemiology of antibiotic use in a neonatal intensive care unit. Infect. Control Hosp. Epidemiol., 15, 156-162.
35. Fluit, A. C, Verhoef, J., Schmitz, F. J., European SENTRY Participants, 2001, Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY antimicrobial surveillance program 1997-1998. Eur J. Clin. Microbiol. Infect. Dis., 20, 617-625.
36. Fridkin, S. K., Steward, C. D., Edwards, J. R., Pryor, E. R., McGowan, J. E., Jr., Archibald L. K. et al., 1999, Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE phase 2. Clin. Infect. Dis., 29, 245-252.
37. Fridkin, S. K., Lawton, R, Edwards, J. R., Tenover, F. C, McGowan, J. E., Gaynes, R P., the Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project, and the National Nosocomial Infections Surveillance (NNIS) system hospitals, 2002, Monitoring antimicrobial use and resistance: Comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci. Emerg. Infect. Dis., 8, 702-707'.
38. Garcia-Rodriguez, J. A. and Jones, R N, 2002, Antimicrobial resistance in gram-negative isolates from European intensive care units: Data from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme. J. Chemother, 14, 25-32.
39. Gastmeier, P., Sohr, D., Forster, D., Schulgen, G, Schumacher, M., Daschner, F. et al., 2000, Identifying outliers of antibiotic usage in prevalence studies on nosocomial infections. Infect. Control Hosp. Epidemiol., 21, 324-328.
40. Gerding, D. N, Larson, T. A., Hughes, R. A. et al., 1991, Aminoglycoside resistance and aminoglycoside usage: Ten years of experience in one hospital. Antimicrob. Agents. Chemother, 35, 1284-1290.
41. Gortner, L., 1993, Drug utilisation in preterm and term neonates. Pharmacoeconomics, 4, 437-445.
42. Grupo de Trabajo de Enfermedades Infecciosas de la Sociedad Española de Medicina Intensiva y Unidades Coronarias (GTEI-SEMIUC). ENVIN-UCI, Estudio Nacional de Vigilancia de Infeccion Nosocomial en Servicios de Medicina Intensiva. Informe, 1996.
43. Gruson, D., Hilbert, G, Vargas, F, Valentino, R., Bebear, C, Allery, A. et al., 2000, Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Am. J. Respir Crit. Care Med., 162, 837-843.
44. Hanberger, H., Garcia-Rodriguez, J. A., Gobernado, M., Goossens, H., Nilsson, L. E., and Struelens, M. J., 1999a, Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units. JAMA, 281, 67-71.
45. Hanberger, H, Nilsson, L. E., Claesson, B. et al., 1999b, New species-related MIC breakpoints for early detection of development of resistance among Gram-negative bacteria in Swedish intensive care units. J. Antimicrob. Chemother, 44, 611-619; 35, 152-160.
46. Hanberger, H., Nilsson, L. E., and the SCOPE study Group, 2000, May, Higher incidence of antibiotic resistance among nosocomial bacteria in Nordic intensive care units (ICUs) compared to primary care centres. Abstracts of the 3rd European Congress of Chemotherapy, Madrid Abstr. T 136.
47. Hanberger, H, Diekema, D., Fluit, A., Jones, R., Struelens, M., Spencer, R. et al., 2001a, Surveillance of antibiotic resistance in European ICUs 2001a, J. Hosp. Infect., 48, 161-176.
48. Hanberger, H., Erlandsson, M., Burman, L. G., Cars, O., Gill, H., Lindgren, S., Nilsson, L. E., Olsson-Liljequist, B., Walther, S., and ICU-Strama Study Group, 2004, High Antibiotic Susceptibility among Bacterial Athogens in Swedish ICUs, Scand. J. Infect. Dis., 36, 24-30.
49. Ibrahim, E. H, Ward, S., Sherman, G et al., 2001, Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit. Care Med., 29, 1109-1115.
50. ICU-STRAMA 1999-2000, Surveillance of antibiotic consumption and antibiotic resistance and its relationship to severity of illness and infection control in Swedish intensive care units. Available from http://dior.imt.liu.se/ icustrama/
51. Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Surveillance Report, 1999, June, Data Summary from January 1996 through December 1997, A report from the National Nosocomial Infections Surveillance (NNIS) System. Am. J. Infect. Control, 27, 279-284.
52. Kiivet, R. A., Dahl, M. L., Llerena, A., Maimets, M., Wettermark, B., and Berecz, R., 1998, Antibiotic use in 3 European university hospitals. Scand. J. Infect. Dis., 30, 277-280.
53. Kollef, M. H., and Ward, S., 1998, The influences of mini-BAL cultures on patient outcomes: Implications for antibiotic management of ventilator-associated pneumonia. Chest, 113, 412-420.
54. Kollef, M. H, Sherman, G, Ward S., and Fraser, V J., 1999, Inadequate antimicrobial treatment of infections: A risk factor for hospital mortality among critically ill patients. Chest, 115, 462-474.
55. Kollef, M. H, Ward S., Sherman, G, Prentice, D., Schaiff, R., Huey, W et al., 2000, Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Crit. Care Med., 28, 3456-3464.
56. Kollef, M. H, 2003, Selective digestive decontamination should not be routinely employed. Chest, 123(Suppl.), 464S-468S.
57. Lemmen, S. W, Häfner, H., Kotterik, S., Lütticken, R., and Töpper, R., 2000, Influence of an infectious disease service on antibiotic prescription behavior and selection of multiresis-tant pathogens. Infection, 28, 384-387.
58. Lingnau, W and Allerberger, F., 1994, Control of an outbreak of methicillin-resistant Staphylococcus aureus (MRSA) by hygienic measure in a general intensive care unit. Infection, 22(Suppl. 2), S135-S139.
59. Mathai, D., Jones, J. N, Stilwell, M., and Pfaller, M. A., 2000, Three year analysis of pathogen occurrence and antimicrobial resistance in 315 intensive care units within 71 participating medical centres (32 nations). Report from the SENTRY antimicrobial surveillance program (1997-99). Presented in part at the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Session 108, Poster 1027.
60. Monnet, D. L., Suetens, C, Jepsen, O. B., Burman, L. G, Carsauw, H., Gastmeier, P. et al., and the European Strategy for Antibiotic Prophylaxis (ESAP) Project Team, 2000, Overall antimicrobial use and control strategies in intensive care units from 6 European countries. 4th Decennial International Conference on Nosocomial and Healthcare-Associated Infections, Atlanta, GA, 2000, abstr. P-S2-03. Infect. Control Hosp. Epidemiol, 21, 88
61. MYSTIC (AstraZeneca, data on file), 2003.
62. Naaber, P., Kõljalg, S., and Maimets, M., 2000, Antibiotic usage and resistance-trends in Estonian University Hospitals. Int. J. Antimicrob. Agents, 16, 309-315.
63. Paterson, D. L., 2003, Restrictive antibiotic policies are appropriate in intensive care units. Crit. Care Med., 31(Suppl.), S25-S28.
64. Pestotnik, S. L., Classen, D. C, Evans, R. S. et al., 1996, Implementing antibiotic practice guidelines through computer-assisted decision support: Clinical and financial outcomes. Ann. Intern. Med., 124, 884-890.
65. Petersen, I. S., Hesselbjerg, L., Jørgensen, L., Renstrup, J., Barnung, S., Schierbeck, J. et al., 1999, High antibiotic consumption in Danish intensive care units? APMIS, 107, 989-996.
66. Pittet, D., Hugonnet, S., Harbarth, S. et al., 2000, Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet, 356, 1307-1312.
67. Raymond D. P., Pelletier, S. J., Crabtree, T. D. et al., 2001, Impact of rotating empiric antibiotic schedule on infectious mortality in an intensive care unit. Crit. Care Med., 29, 1101-1108.
68. Regnier, B., 1996, Epidemiology on control of antibiotic multiresistant bacteria in hospitals (in French). Path. Biol., 44, 113-123.
69. Rhinehart, E., Smith, N. E., Wennersten, C. et al., 1990, Rapid dissemination of beta-lactamase producing aminoglycoside resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N. Engl. J. Med., 323, 1814-1818.
70. Røder, B. L., Nielsen, S. L., Magnussen, P., Engquist, A., and Frimodt-Møller, N, 1993, Antibiotic usage in an intensive care unit in a Danish university hospital. J. Antimicrob. Chemother, 32, 633-642.
71. Rodriguez-Villalobos, H., Jones, R, and Struelens, M. J., 2002, Epidemiology of antibiotic resistance of bacterial pathogens from intensive care units: The SENTRY surveillance program in Europe 2000. Clin. Microbiol. Infect., 8(Suppl. 1), Abstract: P908.
72. Ruckdeschel, G., Grimm, H., Machka, K., and Wiedemann, B., 1998, Comparison of antibiotic resistance in clinical bacterial strains from general wards vs. intensive care unit patients. In Abstracts of the 2nd European Congress of Chemotherapy. Hamburg, Abstract T253.
73. Scott, G, 2000, Prevention and control of infections in intensive care. Intensive Care Med., 26(Suppl. 1), S22-S25.
74. Schwalbe, R. S., Stapleton, J. T, and Gilligan, P. H., 1987, Emergence of vancomycin resistance in coagulase-negative staphylococci. N. Engl. J. Med., 316, 927-931.
75. Singh, N, Rogers, P., Atwood, C. W. et al., 2000, Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am. J. Respir Crit. Care Med., 162, 505-511.
76. Souweine, B., Traore, O., Aublet-Cuvelier, B. et al., 2000, Role of infection control measures in limiting morbidity associated with multi-resistant organisms in critically ill patients. J. Hosp. Infect., 45, 107-116.
77. Srinivasan, A., Song, X., Ross, T, Merz, W., Brower, R., and Perl, T. M., 2002, A prospective study to determine whether cover gowns in addition to gloves decrease nosocomial transmission of vancomycin-resistant enterococci in an intensive care unit. Infect. Control Hosp. Epidemiol., 23, 424-428.
78. Stephen, J., Mutnick, A., and Jones, R. N, 2002, Assessment of pathogens and resistance (R) patterns among intensive care unit (ICU) patients in North America (NA): Initial Report from the SENTRY Antimicrobial Surveillance Program (2001). 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, Abstract: C2-297.
79. Struelens, M. J., Byl, B., and Vincent, J. L., 1999, Antibiotic policy: A tool for controlling resistance of hospital pathogens. Clin. Microbiol. Infect., 5, S19-S24.
80. Tarp, B. D., and Møller, J. K., 1997 [Utilization of antibiotics at the Arhus Municipal Hospital. A prevalence study]. Ugeskr Laeger, 159, 936-939.
81. Tullus, K., Berglund, B., Fryklund, B., Kühn, I., and Burman, L. G., 1988, Epidemiology of fecal strains of the family Enterobacteriaceae in 22 neonatal wards and influence of antibiotic policy. J. Clin. Microbiol., 26, 1166-1170.
82. Vlahovic-Palcevski, V, Morovic, M., and Palcevski, G., 2000, Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J. Clin. Pharmacol, 56, 97-101.
83. Vincent, J. L., Bihari, D. J., Suter, P. M., Bruining, H. A., White, J., Nicolas-Chanoin, M.-H. et al., 1995, The prevalence of nosocomial infection in intensive care units in Europe. JAMA, 274, 639-644.
84. Voss, A., Milatovic, D., Wallrauch-Schwarz, C. et al., 1994, Methicillin-resistant Staphylococcus aureus in Europe. Eur J. Clin. Microbiol. Infect. Dis., 13, 50-55.
85. Voss, A. and Widmer, A. F., 1997, No time for handwashing!? Handwashing versus alcoholic rub: Can we afford 100% compliance? Infect. Control Hosp. Epidemiol., 18, 205-208.
86. Walther, S. M., Erlandsson, M., Burman, L. G, Cars, O., Gill, H., Hoffman, M. et al., and the Icustrama Study Group, 2002, Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol. Scand., 46, 1075-1081.
87. White, R. L., Friedrich, L. V, Mihm, L. B., and Bosso, J. A., 2000, Assessment of the relationship between antimicrobial usage and susceptibility: Differences between the hospital and specific patient-care areas. Clin. Infect. Dis., 31, 16-23.
88. Zaidi, M., Sifuentes-Osornio, J., Rolon, A. L. et al., 2002, Inadequate therapy and antibiotic resistance. Risk factors for mortality in the intensive care unit. Arch. Med. Res., 33, 290-294.